SCOPUS 정보 검색 플랫폼

Volumn 49, Issue 2, 2008, Pages 135-138

Future prospects in developing of dengue vaccines;Perspectivas futuras en el desarrollo de vacunas para dengue

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; DNA VACCINE; INACTIVATED VACCINE; LIVE VACCINE; SUBUNIT VACCINE;

ARBOVIRUS; DENGUE; DISEASE CONTROL; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; FLAVIVIRUS; HUMAN; PROPHYLAXIS; REVIEW; SEROTYPE; SOCIOECONOMICS; WORLD HEALTH ORGANIZATION;

ADULT; CHILD; DENGUE; DENGUE VIRUS; FORECASTING; HUMANS; VACCINES, ATTENUATED; VACCINES, DNA; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 49449092413 PISSN: 05355133 EISSN: 05355133 Source Type: Journal
DOI: None Document Type: Review

Times cited : (3)

References (11)

1
- 0003487519
- World Health Organization, 2nd ed. World Health Organization, Geneva, Switzerland
- nd ed. World Health Organization, Geneva, Switzerland 1997.
- (1997) Dengue haemorrhagic fever: Diagnosis, treatment, prevention and control

2
- 0031823546
- Dengue and Dengue Hemorrhagic Fever
- Gubler D. Dengue and Dengue Hemorrhagic Fever. Clinical Microbiology Rev 1998; 11(3):480-496.
- (1998) Clinical Microbiology Rev , vol.11 , Issue.3 , pp. 480-496
- Gubler, D.¹

3
- 33947542435
- The evolutionary biology of dengue virus
- discussion 187-92, 251-253
- Holmes EC. The evolutionary biology of dengue virus. Novartis Found Symp 2006; 277:177-87; discussion 187-92, 251-253.
- (2006) Novartis Found Symp , vol.277 , pp. 177-187
- Holmes, E.C.¹

4
- 0036728433
- Hacia el control integral del dengue.
- Valero N. Hacia el control integral del dengue. Invest Clín 2002; 43(3):141-144.
- (2002) Invest Clín , vol.43 , Issue.3 , pp. 141-144
- Valero, N.¹

5
- 2142827156
- Dengue: Defining protective versus pathologic immunity
- Rothman A. Dengue: defining protective versus pathologic immunity. The Journal of Clinical Investigation 2004; 113(7):946-951.
- (2004) The Journal of Clinical Investigation , vol.113 , Issue.7 , pp. 946-951
- Rothman, A.¹

6
- 34250365710
- Prospects for a dengue virus vaccine
- Whitehead S, Blaney J, Durbin A, Murphy B. Prospects for a dengue virus vaccine. Nature 2007; 5:518-528.
- (2007) Nature , vol.5 , pp. 518-528
- Whitehead, S.¹ Blaney, J.² Durbin, A.³ Murphy, B.⁴

7
- 0038024238
- Traditional and novel approaches to flavivirus vaccines
- Konstantin P, Farshad D, Trent T. Traditional and novel approaches to flavivirus vaccines. International Journal for Parasitology 2003; 33:567-582.
- (2003) International Journal for Parasitology , vol.33 , pp. 567-582
- Konstantin, P.¹ Farshad, D.² Trent, T.³

8
- 34547275156
- Vacunas contra el dengue: Una revisión de las vacunas candidatas en etapas avanzadas de desarrollo.
- Hombach J. Vacunas contra el dengue: Una revisión de las vacunas candidatas en etapas avanzadas de desarrollo. Rev Panam Salud Pública 2007; 21(4):254-260.
- (2007) Rev Panam Salud Pública , vol.21 , Issue.4 , pp. 254-260
- Hombach, J.¹

9
- 0037136939
- The future of dengue vaccines
- Halstead S, Deen J. The future of dengue vaccines. The Lancet 2002; 360:1243-1245.
- (2002) The Lancet , vol.360 , pp. 1243-1245
- Halstead, S.¹ Deen, J.²

10
- 0034897886
- Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine
- Guirakhoo F, et al. Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol 2001; 75:7290-7304.
- (2001) J Virol , vol.75 , pp. 7290-7304
- Guirakhoo, F.¹

11
- 38149076067
- Evolución molecular del virus dengue: Un área de investigación prioritaria.
- Añez G. Evolución molecular del virus dengue: un área de investigación prioritaria. Invest Clín 2007; 48(3):273-276.
- (2007) Invest Clín , vol.48 , Issue.3 , pp. 273-276
- Añez, G.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.